Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.81 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.81 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | SOAT2 | O75908 | 1/20 | 0.47 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16591365 | 0.95 | LMNA (0.74) | LMNAKMT2ASMN1; SMN2GAAHTT | |
| SCHEMBL4315481 | 0.90 | LMNA (1.00) | LMNAKMT2ASMN1; SMN2GAAHTT | |
| Hydrochloric Acid SCHEMBL28857355 | 0.88 | LMNA (0.97) | LMNAKMT2ASMN1; SMN2GAAHTT | |
| Iodide SCHEMBL30758614 | 0.88 | LMNA (0.97) | LMNAKMT2ASMN1; SMN2GAAHTT | |
| SCHEMBL19138403 | 0.85 | KMT2A (0.73) | LMNAKMT2ASMN1; SMN2MEN1 | |
| SCHEMBL14788839 | 0.84 | LMNA (0.71) | LMNAKMT2ASMN1; SMN2GAAHTT | |
| SCHEMBL24574897 | 0.83 | LMNA (0.85) | LMNAKMT2ASMN1; SMN2GAAHTT | |
| SCHEMBL31155751 | 0.83 | LMNA (0.69) | LMNAKMT2ASMN1; SMN2HTTSOAT2 | |
| SCHEMBL24574896 | 0.83 | LMNA (0.69) | LMNAKMT2ASMN1; SMN2MEN1 | |
| SCHEMBL8461958 | 0.82 | LMNA (0.59) | LMNAKMT2ASMN1; SMN2GAAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3049387-B1 | THERMOPLASTIC POLYMER COMPOSITION | MILLIKEN & CO (US) | 2020-11-11 | — | — | EP | disclosed |
| US-9200142-B2 | Thermoplastic polymer composition | MILLIKEN & COMPANY (US) | 2015-12-01 | — | — | US | disclosed |
| US-9200144-B2 | Thermoplastic polymer composition | MILLIKEN & COMPANY (US) | 2015-12-01 | — | — | US | disclosed |
| US-9200142-B2 | Thermoplastic polymer composition | MILLIKEN & COMPANY (US) | 2015-12-01 | — | — | US | disclosed |
| US-9193845-B2 | Thermoplastic polymer composition | MILLIKEN & COMPANY (US) | 2015-11-24 | — | — | US | disclosed |
| US-9120914-B2 | Thermoplastic polymer composition | MILLIKEN & COMPANY (US) | 2015-09-01 | — | — | US | disclosed |
| US-20150094406-A1 | THERMOPLASTIC POLYMER COMPOSITION | MILLIKEN & COMPANY | 2015-04-02 | — | — | US | disclosed |
| US-20150087759-A1 | THERMOPLASTIC POLYMER COMPOSITION | MILLIKEN & COMPANY | 2015-03-26 | — | — | US | disclosed |
| US-20150087757-A1 | THERMOPLASTIC POLYMER COMPOSITION | MILLIKEN & COMPANY | 2015-03-26 | — | — | US | disclosed |
| US-20150087757-A1 | THERMOPLASTIC POLYMER COMPOSITION | MILLIKEN & COMPANY | 2015-03-26 | — | — | US | disclosed |
| US-20150087758-A1 | THERMOPLASTIC POLYMER COMPOSITION | MILLIKEN & COMPANY | 2015-03-26 | — | — | US | disclosed |
| US-8951647-B2 | Organic electroluminescence device | MERCK PATENT GMBH (DE) | 2015-02-10 | — | — | US | disclosed |
| WO-1999048529-A1 | RETINOID-GLITAZONE COMBINATIONS | WARNER-LAMBERT COMPANY (US) | 1999-09-30 | — | — | WO | disclosed |
| EP-0808159-A1 | USE OR RETINOIDS TO LOWER PLASMA LEVELS OF LIPOPROTEIN (a) | WARNER-LAMBERT COMPANY (US) | 1997-11-26 | — | — | EP | disclosed |
| WO-1996024344-A1 | USE OF RETINOIDS TO LOWER PLASMA LEVELS OF LIPOPROTEIN (a) | WARNER-LAMBERT COMPANY (US) | 1996-08-15 | — | — | WO | disclosed |
| US-5489611-A | ADMINISTERING A RETINOID COMPOUND | WARNER-LAMBERT COMPANY (US) | 1996-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150087757-A1 | THERMOPLASTIC POLYMER COMPOSITION | PARG, PUF60, MCM7 | LMNA 347/4885KMT2A 1047/4885SMN1; SMN2 933/4885 |
| US-20150087758-A1 | THERMOPLASTIC POLYMER COMPOSITION | ERCC4, SMCHD1, XRCC5 | LMNA 855/4885KMT2A 1432/4885SMN1; SMN2 1807/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.